At a Glance... The Soul of PHMC GPE LLC

Positioned to Influence... Appointed to Succeed !



Promoted Posts
China takes the Arctic Route: First ship set to arrive in Europe via the Northeast Passage

The Europe #Arctic Express and could revolutionize European trade, shortening the distance between #China and #Europe by ten days (it takes 18 days via the Arctic, compared to about 30 using the Suez Canal).

The ship will set sail with 5,000 containers from the port of Qingdao, opposite North Korea, and then dock in Europe at the ports of Felixstowe in Great Britain, Rotterdam, Hamburg, and Gdansk. A stable flow of ships through this new route would render the ports of the Mediterranean marginal. This revolution was made possible by climate change. The shrinking of the polar ice cap is significantly accelerating the melting of the ice, which in those latitudes is occurring at a rate of 12 percent every ten years. It is only “thanks” to this that one can today speak of a “Northwest Passage.” In recent years, Russian and Chinese container ships have mainly navigated the Arctic route.

According to Norway’s Centre for High North Logistics (CHNL), between the beginning of June and the end of August, approximately 52 Russian or Chinese ships transited through this route, mainly loaded with Russian oil for export.
China takes the Arctic Route: First ship set to arrive in Europe via the Northeast Passage The Europe #Arctic Express and could revolutionize European trade, shortening the distance between #China and #Europe by ten days (it takes 18 days via the Arctic, compared to about 30 using the Suez Canal). The ship will set sail with 5,000 containers from the port of Qingdao, opposite North Korea, and then dock in Europe at the ports of Felixstowe in Great Britain, Rotterdam, Hamburg, and Gdansk. A stable flow of ships through this new route would render the ports of the Mediterranean marginal. This revolution was made possible by climate change. The shrinking of the polar ice cap is significantly accelerating the melting of the ice, which in those latitudes is occurring at a rate of 12 percent every ten years. It is only “thanks” to this that one can today speak of a “Northwest Passage.” In recent years, Russian and Chinese container ships have mainly navigated the Arctic route. According to Norway’s Centre for High North Logistics (CHNL), between the beginning of June and the end of August, approximately 52 Russian or Chinese ships transited through this route, mainly loaded with Russian oil for export.
Like
1
0 Comments 0 Shares 28K Views
Recent Updates
All Countries
  • US approves use of landmark pancreatic cancer drug that’s shown to boost survival


    The Food and Drug Administration approves a groundbreaking new drug for advanced pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of cancer.


    FDA officials give expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90 percent of pancreatic cancer cases. It’s an approach that previously eluded drugmakers for decades. The daily pills will be sold by Revolution Medicines under the brand name Rasonque. A one-month supply would cost approximately $39,800, the company announced.


    Patients taking the drug nearly doubled their survival time, with fewer severe side effects, in a study that randomly assigned them to receive the experimental treatment or more chemotherapy. The company-funded study enrolled 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment. Patients getting the new treatment lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients. Side effects included skin rash, mouth sores, diarrhea, and other digestive issues. “This is one of the most anticipated approvals I can think of,” Dr. Andrew Coveler of the Fred Hutch Cancer Center says. “This medicine is not a cure but a significant improvement.”


    Pancreatic cancer is among the deadliest forms in large part because it is hard to detect before it starts spreading to other organs. The American Cancer Society estimates that about 67,000 new cases will be diagnosed in the United States this year and more than 52,000 people will die from the disease. The five-year overall survival rate is 13%.

    US approves use of landmark pancreatic cancer drug that’s shown to boost survivalThe Food and Drug Administration approves a groundbreaking new drug for advanced pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of cancer. FDA officials give expedited approval to the first-of-a-kind pill, called daraxonrasib, which blocks a mutated protein that fuels tumor growth in more than 90 percent of pancreatic cancer cases. It’s an approach that previously eluded drugmakers for decades. The daily pills will be sold by Revolution Medicines under the brand name Rasonque. A one-month supply would cost approximately $39,800, the company announced. Patients taking the drug nearly doubled their survival time, with fewer severe side effects, in a study that randomly assigned them to receive the experimental treatment or more chemotherapy. The company-funded study enrolled 500 patients whose metastatic, or spreading, cancer had quit responding to prior treatment. Patients getting the new treatment lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients. Side effects included skin rash, mouth sores, diarrhea, and other digestive issues. “This is one of the most anticipated approvals I can think of,” Dr. Andrew Coveler of the Fred Hutch Cancer Center says. “This medicine is not a cure but a significant improvement.” Pancreatic cancer is among the deadliest forms in large part because it is hard to detect before it starts spreading to other organs. The American Cancer Society estimates that about 67,000 new cases will be diagnosed in the United States this year and more than 52,000 people will die from the disease. The five-year overall survival rate is 13%.
    Like
    1
    0 Comments 0 Shares 190 Views
  • Like
    1
    0 Comments 0 Shares 127 Views
  • HO1.US
    [UPDATE-Aug 27, 2026-Israel-Iran War] Gaza-Hamas, Lebanon-Hezbollah, Syria: Real Time Reaction and Analysis
    Israel is considering expelling British officials from the US-led coordination centre for post-war Gaza, the Financial Times reports.
    Like
    1
    0 Comments 0 Shares 136 Views
  • HO1.US
    [UPDATE – Aug 27th, 2026] Ukraine – Russia WAR: Situation on the Ground – August 2026, 2/2
    Russia-Ukraine War. This is a developing story that HO1 will continue to monitor. Check back for updates.
    0 Comments 0 Shares 137 Views
  • 𝐃𝐞𝐥𝐨𝐢𝐭𝐭𝐞 𝐭𝐨 𝐏𝐚𝐲 $𝟐𝟏.𝟓 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐨 𝐒𝐞𝐭𝐭𝐥𝐞 𝐅𝐞𝐝𝐞𝐫𝐚𝐥 𝐀𝐥𝐥𝐞𝐠𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐑𝐚𝐜𝐞- 𝐚𝐧𝐝 𝐒𝐞𝐱-𝐁𝐚𝐬𝐞𝐝 𝐁𝐢𝐚𝐬



    The company used race and sex in employment decisions connected to its diversity initiatives, the Justice Dept. said. Deloitte denied the allegations.


    #AssHoleCo #FofS

    𝐃𝐞𝐥𝐨𝐢𝐭𝐭𝐞 𝐭𝐨 𝐏𝐚𝐲 $𝟐𝟏.𝟓 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐭𝐨 𝐒𝐞𝐭𝐭𝐥𝐞 𝐅𝐞𝐝𝐞𝐫𝐚𝐥 𝐀𝐥𝐥𝐞𝐠𝐚𝐭𝐢𝐨𝐧𝐬 𝐨𝐟 𝐑𝐚𝐜𝐞- 𝐚𝐧𝐝 𝐒𝐞𝐱-𝐁𝐚𝐬𝐞𝐝 𝐁𝐢𝐚𝐬 The company used race and sex in employment decisions connected to its diversity initiatives, the Justice Dept. said. Deloitte denied the allegations. #AssHoleCo #FofS
    Haha
    1
    0 Comments 0 Shares 591 Views
  • HO1.US
    CIA Director Ratcliffe’s Surprise Moscow Trip Raises Questions Over Russia -Ukraine and Iran
    US officials confirmed it. A rare trip that comes as Washington’s efforts to end Russia’s war against Ukraine have stalled and tensions over Moscow’s
    Like
    1
    0 Comments 0 Shares 342 Views
  • Like
    1
    0 Comments 0 Shares 377 Views
  • HO1.US
    [UPDATE-Aug 26, 2026-Israel-Iran War] Gaza-Hamas, Lebanon-Hezbollah, Syria: Real Time Reaction and Analysis
    Druze residents of southern Syria held a striking show of support for Israel on Monday, August 24, driving through the Suwayda area in a “convoy of gratitude”
    Like
    1
    0 Comments 0 Shares 403 Views
  • HO1.US
    [UPDATE – Aug 26th, 2026] Ukraine – Russia WAR: Situation on the Ground – August 2026, 2/2
    Russia-Ukraine War. This is a developing story that HO1 will continue to monitor. Check back for updates.
    Like
    1
    0 Comments 0 Shares 389 Views
  • Aug. 25 - US military transport plane lands in Moscow



    An American Boeing C-17A Globemaster III military transport aircraft has reportedly landed in Moscow, according to online air traffic monitoring systems.


    According to available data, the aircraft, which departed from Andrews Air Force Base near Washington, made a stop in Riga before arriving in Moscow around 7:00 a.m. UTC


    A source within EU air traffic control authorities reported that the plane, having originally flown from Andrews Air Force Base to Latvia, had indeed continued its journey toward the Russian border. The source confirmed that the aircraft proceeded toward Russia's border after its stop in Riga. Additionally, the source noted that prior to this, the plane had also visited Charleston Airport.

    Aug. 25 - US military transport plane lands in Moscow An American Boeing C-17A Globemaster III military transport aircraft has reportedly landed in Moscow, according to online air traffic monitoring systems. According to available data, the aircraft, which departed from Andrews Air Force Base near Washington, made a stop in Riga before arriving in Moscow around 7:00 a.m. UTC A source within EU air traffic control authorities reported that the plane, having originally flown from Andrews Air Force Base to Latvia, had indeed continued its journey toward the Russian border. The source confirmed that the aircraft proceeded toward Russia's border after its stop in Riga. Additionally, the source noted that prior to this, the plane had also visited Charleston Airport.
    Like
    1
    0 Comments 0 Shares 967 Views
More Stories
You have merits left
Sponsored

HO1.US, the #1 Holistic All In One Worldwide Overview,
GeoPolitics, Politics, Economy, Military & Defense ,...

Sponsored



Psychanalyse, Psychothérapie, Coaching - Chantal MAILLE.
Je vous propose des séances par Téléphone, Skype, des réponses à vos questions par eMail.
Vous vous posez des questions : Pour qui ? Pourquoi ? Quand ?

Sponsored

Not yet a #HO1 Member... Select your Member ship & register !

Why Subscribe? 1. To access genuine and 100% validated Information and News 2. All In One Place and ZERO annoying advert 3. To Access the Latest News in Real Time 4. Multiple languages...

CryptoCurrency Market
X-Pulse, the HO1 Think Tank https://thinktank.x-pulse.org/